Opens in a new tab

Green Knitwear Manufacturing Platform

Green Knitwear Manufacturing Platform
Country
BangladeshBangladesh
Listing ID
L#20261162
Target Price
$5,000,000
Revenue
$4,000,000
EBITDA
TBA

Description

The target is an established Bangladesh-based knitwear manufacturer serving international buyers across the EU, UK and US markets. The company currently operates from a 6,000 sqm site with approximately 2,500 sqm of production space and generates around USD 4M in annual turnover.

The business is seeking USD 5M of growth capital to establish a bonded production facility, modernize its machinery, introduce green and automated manufacturing technologies, and strengthen working capital.

The expansion is designed to increase production capacity by approximately 2.5x and create a more integrated, technology-driven manufacturing platform.

Investment Area Amount
Bonded Warehouse USD 1.20M
Green Production Expansion USD 1.00M
Machinery & Automation USD 1.80M
Working Capital USD 0.60M
Compliance & Certification USD 0.40M
Total USD 5.00M

The proposed investment combines infrastructure development, machinery modernization, automation, working capital and compliance upgrades.

INVESTMENT HIGHLIGHTS

  • USD 5.0M total investment requirement
  • Established knitwear OEM/ODM manufacturer
  • Existing EU, UK & US buyer relationships
  • Current annual turnover of approximately USD 4.0M
  • Expansion expected to increase turnover to approximately USD 9.0M
  • Existing 6,000 sqm landholding with expandable production facilities
  • 290+ employees and established manufacturing operations
  • BSCI, SEDEX and OEKO-TEX certifications
  • Proposed 100 tons/month fabric import capacity
  • Targeted 20–25% net margin following expansion
  • Projected investor IRR of 17–21%
  • Multiple potential investment structures, including 40–49% JV participation or 100% acquisition

GREEN MANUFACTURING PLATFORM

The project is intended to establish a China–Bangladesh green technology partnership, incorporating:

  • Solar power generation
  • Water recycling
  • Low-emission generators
  • Heat-recovery systems
  • Digital waste-reduction technologies
  • Automated production equipment

The Chinese strategic partner would contribute capital, machinery and automation, supply-chain integration and order support, while the Bangladesh operating partner contributes land, management, workforce, compliance capabilities and existing buyer relationships.

MARKET & COMPETITIVE POSITION

The project benefits from several stated operating advantages:

  • Established international buyer relationships
  • Access to EU/UK export markets
  • Competitive Bangladesh labor costs
  • Duty-free raw-material import structure under the proposed bonded model
  • Existing skilled workforce
  • Chinese manufacturing technology and automation
  • Potential productivity improvement of 20–30% from the proposed technology upgrade

These advantages are presented in the source deck as key drivers of the planned expansion.

Basic Details

Listing ID
L#20261162
Country
Bangladesh
Industry
Manufacturing
Deal Status
Available
Target Price
$5,000,000
Revenue
$4,000,000
EBITDA
TBA
Revenue Multiple
1.25x
EBITDA Multiple
TBD

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000